Literature DB >> 7777654

Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms.

E Redei1, E W Freeman.   

Abstract

The present study extends a previous report of lower plasma ACTH levels in women with premenstrual syndrome (PMS) compared with asymptomatic controls. Plasma levels of estradiol and progesterone were measured daily in 10 women with confirmed PMS and 8 asymptomatic women. Daily symptom reports were maintained during the same menstrual cycle. Both estradiol and progesterone levels were consistently, but not significantly, higher throughout the cycle in PMS subjects compared with controls. From the follicular to the early luteal phase, estradiol levels were significantly higher in a previously defined PMS subgroup 2 with more severe symptoms throughout the cycle compared with both the less severe PMS subgroup 1 and controls. Progesterone levels were significantly and positively correlated with PMS symptoms along the entire menstrual cycle, preceding the symptoms by 5-7 days. These preliminary results provide support for the hypothesis that the presence of progesterone at early luteal phase levels is required for PMS symptoms to occur.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777654     DOI: 10.1016/0306-4530(94)00057-h

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  22 in total

1.  Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review.

Authors:  K Wyatt; P Dimmock; P Jones; M Obhrai; S O'Brien
Journal:  BMJ       Date:  2001-10-06

Review 2.  The pathophysiologic background for current treatments of premenstrual syndromes.

Authors:  Uriel Halbreich
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 3.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

4.  Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability.

Authors:  Ethan H Beckley; Angela C Scibelli; Deborah A Finn
Journal:  Psychoneuroendocrinology       Date:  2010-12-15       Impact factor: 4.905

5.  Cutaneous postural vasoconstriction is modified by exogenous but not endogenous female hormones in young women.

Authors:  Gemma D Bishop; Margaret D Brown
Journal:  Clin Auton Res       Date:  2007-01-30       Impact factor: 4.435

6.  Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro.

Authors:  Qi YE; Qiao-yan ZHANG; Cheng-jian ZHENG; Yang WANG; Lu-ping QIN
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

7.  Perceived stress and severity of perimenstrual symptoms: the BioCycle Study.

Authors:  Audra L Gollenberg; Mary L Hediger; Sunni L Mumford; Brian W Whitcomb; Kathleen M Hovey; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Womens Health (Larchmt)       Date:  2010-05       Impact factor: 2.681

Review 8.  The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research.

Authors:  Justin J Anker; Marilyn E Carroll
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

9.  Cigarette smoking and the development of premenstrual syndrome.

Authors:  Elizabeth R Bertone-Johnson; Susan E Hankinson; Susan R Johnson; Joann E Manson
Journal:  Am J Epidemiol       Date:  2008-08-13       Impact factor: 4.897

Review 10.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.